Indirect recognition of t-cell epitopes derived from the α3 and transmembrane domain of HLA-A2

被引:17
作者
Hanvesakul, R.
Maillere, B.
Briggs, D.
Baker, R.
Larche, M.
Ball, S. [1 ]
机构
[1] Univ Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England
[2] Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England
[3] CEA, Dept Ingn & Etud Prot, Saclay, France
[4] Natl Blood Serv, H&I Lab, Birmingham, W Midlands, England
[5] St James Hosp, Dept Renal Med, Leeds, W Yorkshire, England
[6] Univ London Imperial Coll Sci & Technol, Natl Heart & Lung Inst, London, England
关键词
alloantibody; allorecognition; epitope; peptide;
D O I
10.1111/j.1600-6143.2007.01743.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Indirect allorecognition has been implicated in the mechanism of chronic rejection and alloantibody formation but precise definition of the epitopes involved has been limited. We have undertaken a detailed assessment of the antigenic properties of peptides derived from HLA-A2. Candidate epitopes were identified in vitro by assessment of MHC class II binding. The immune response to these epitopes was determined in patients awaiting a renal transplant by the assessment of PBMC activation using gamma-interferon ELISPOT. Twenty-two of fifty-five patients responded to peptides from HLA-A2 and this was associated with but not confined to those who had made antibody to HLA-A2 (14/18). Nineteen of twenty-two patients responded to peptides derived from the hypervariable alpha 1 and alpha 2 domains and 18/22 responded to peptides from the alpha 3 and transmembrane domain, the sequences of which show little polymorphism. In six patients, the sequence of these peptides was identical to self, that is, the response was autoimmune. The finding of indirect epitopes derived from regions of MHC class I that exhibit little polymorphism provides a novel perspective on the immune response to alloantigen and has potential implications for the development of specific therapies.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 52 条
  • [1] Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy
    Baker, RJ
    Hernandez-Fuentes, MP
    Brookes, PA
    Chaudhry, AN
    Cook, HT
    Lechler, RI
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 7199 - 7206
  • [2] DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION
    BENICHOU, G
    TAKIZAWA, PA
    OLSON, CA
    MCMILLAN, M
    SERCARZ, EE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 305 - 308
  • [3] A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling
    Boytim, ML
    Lilly, P
    Drouvalakis, K
    Lyu, SC
    Jung, R
    Krensky, AM
    Clayberger, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (10) : 1447 - 1453
  • [4] Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells:: A potential explanation for the blood-transfusion effect
    Bushell, A
    Karim, M
    Kingsley, CI
    Wood, KJ
    [J]. TRANSPLANTATION, 2003, 76 (03) : 449 - 455
  • [5] Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
    Chen, TC
    Waldmann, H
    Fairchild, PJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (12) : 1754 - 1762
  • [6] SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES
    CHICZ, RM
    URBAN, RG
    GORGA, JC
    VIGNALI, DAA
    LANE, WS
    STROMINGER, JL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) : 27 - 47
  • [7] Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide
    Chowdhury, NC
    Saborio, DV
    Garrovillo, M
    Chandraker, A
    Magee, CC
    Waaga, AM
    Sayegh, MH
    Jin, MX
    Oluwole, SF
    [J]. TRANSPLANTATION, 1998, 66 (08) : 1059 - 1066
  • [8] Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
    Ciubotariu, R
    Liu, ZR
    Colovai, AI
    Ho, E
    Itescu, S
    Ravalli, S
    Hardy, MA
    Cortesini, R
    Rose, EA
    Suciu-Foca, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 398 - 405
  • [9] Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28
    Dankers, MKA
    Roelen, DL
    Van Der Meer-Prins, EMW
    De Lange, P
    Korfage, N
    Smits, JMA
    Persijn, GG
    Welsh, KI
    Doxiadis, IIN
    Claas, FHJ
    [J]. TRANSPLANTATION, 2003, 75 (03) : 418 - 420
  • [10] REJECTION OF SKIN ALLOGRAFTS BY INDIRECT ALLORECOGNITION OF DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES
    FANGMANN, J
    DALCHAU, R
    FABRE, JW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1521 - 1529